Pancreatic Cancer Research

ResearcherDublin City UniversityActive in the last 2 years

Martin M. Clynes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3093-8185; OpenAlex author ID A5077091444. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 5 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 14

  1. Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors. Co-author DOI 10.1158/1078-0432.ccr-23-0131↗
  2. miRNA- and Cell Line-Specific Constraints on Precursor miRNA Processing of Stably Transfected Pancreatic Cancer and Other Mammalian Cells. Co-author DOI 10.3390/ijms25115666↗
  3. Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Der… Last author DOI 10.3390/life13030608↗
  4. FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. Co-author DOI 10.1208/s12248-022-00752-8↗
  5. DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models. Co-author DOI 10.1016/j.jconrel.2020.05.046↗
  6. Proteomic analysis of pancreatic ductal adenocarcinoma. Last author DOI 10.1080/14789450.2020.1803743↗
  7. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo. Last author DOI 10.1097/mpa.0000000000001633↗
  8. Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion and Progression of Pancreatic Cancer. Co-author DOI 10.1155/2020/2951921↗
  9. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients. Last author DOI 10.3390/ijms21030962↗
  10. A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. Last author DOI 10.3390/proteomes6040045↗
  11. A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer. Co-author DOI 10.1038/bjc.2017.306↗
  12. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact. Co-author DOI 10.1586/14789450.2016.1167601↗
  13. EGFR and HER2 inhibition in pancreatic cancer. Co-author DOI 10.1007/s10637-012-9891-x↗
  14. Invasive markers identified by gene expression profiling in pancreatic cancer. Co-author DOI 10.1016/j.pan.2011.12.011↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sandra Roche · 7 shared papers, 2018–2023 · strength 0.75
  2. Robert M. Straubinger · 6 shared papers, 2018–2024 · strength 0.73
  3. Fiona O’Neill · 6 shared papers, 2018–2024 · strength 0.73
  4. Paula Meleady · 5 shared papers, 2016–2023 · strength 0.53
  5. Taylor J. Allen-Coyle · 3 shared papers, 2022–2024 · strength 0.52
  6. Finbarr O’Sullivan · 3 shared papers, 2022–2024 · strength 0.52
  7. Kevin C. Conlon · 5 shared papers, 2012–2023 · strength 0.43
  8. Michelle K. Greene · 2 shared papers, 2020–2024 · strength 0.28
  9. Christopher J. Scott · 2 shared papers, 2020–2024 · strength 0.28
  10. Orla Coleman · 3 shared papers, 2016–2020 · strength 0.24
  11. Rozana Abdul Rahman · 2 shared papers, 2020 · strength 0.24
  12. Ray McDermott · 2 shared papers, 2020–2023 · strength 0.23
  13. Annemarie Larkin · 3 shared papers, 2013–2020 · strength 0.20
  14. Tista Roy Chaudhuri · 1 shared paper, 2024 · strength 0.19
  15. Qingxiang Lin · 1 shared paper, 2024 · strength 0.19
  16. Wen Wee Ma · 1 shared paper, 2024 · strength 0.19
  17. Jin Niu · 1 shared paper, 2022 · strength 0.15
  18. Naomi Walsh · 2 shared papers, 2013–2020 · strength 0.14
  19. Shannon R. Nelson · 1 shared paper, 2020 · strength 0.10
  20. Michael C. Johnston · 1 shared paper, 2020 · strength 0.09
  21. Fergal C. Kelleher · 1 shared paper, 2017 · strength 0.06
  22. Dermot O'Sullivan · 1 shared paper, 2017 · strength 0.06
  23. Norma O’Donovan · 1 shared paper, 2013 · strength 0.04
  24. Anna C. Rogers · 1 shared paper, 2012 · strength 0.03
  25. Paul F. Ridgway · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.